Big Tech & Digital Health

Amazon Puts Amwell Co-Founder in Charge of Healthcare Unit

By Intent.Health Team May 28, 2026
Intent Health AI Data Flow

What’s happening

Amazon appointed an Amwell co-founder to lead its healthcare division after a longtime executive departed.

The appointment signals Amazon’s continued push into:

What’s changing / Business impact

This organizational realignment introduces new tactical shifts for tech-driven care:

Why this matters

Amazon has spent years trying to establish a beachhead in healthcare but has faced persistent organizational challenges successfully scaling its healthcare business operations.

This aggressive executive hire shows that big tech still views healthcare as a massive, non-negotiable long-term commercial opportunity, proving that leadership changes may signal major strategic restructuring.
Pharma & R&D

Replimune Reaches Agreement With FDA to Resubmit Melanoma Drug Application

By Intent.Health Team May 29, 2026
Intent Health AI Data Flow

What’s happening

Replimune Group reached an agreement with the FDA on a path to resubmit its melanoma drug application after previous regulatory setbacks.

The company is working to address concerns raised during the review process.

What’s changing / Business impact

The agreement gives the company another opportunity to seek approval and potentially bring the treatment to market.

Why this matters

Melanoma is one of the most serious forms of skin cancer, and companies often spend years and hundreds of millions of dollars developing treatments.